Bard PowerPort Infection Claims – Bloodstream Infection and Sepsis After Port Failure

Bard PowerPort infection lawsuit filings now make up a significant share of one of the largest active medical device MDLs in the country. Patients received these implanted ports for chemotherapy, dialysis, and long-term IV medication. Many later developed bloodstream infections, sepsis, or heart valve infections. They allege the catheter material broke down and harbored bacteria. However, the manufacturer denies the device is defective. This guide explains where the litigation stands as of July 2026.

Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.

Advertisement

Free Case Review

What Is the Bard PowerPort Infection Lawsuit About?

The Bard PowerPort is an implanted vascular access device. C.R. Bard makes it. Becton Dickinson (BD) acquired Bard in 2017 and is a co-defendant. A surgeon places a small reservoir under the skin of the chest or upper arm. A flexible polyurethane catheter runs from that reservoir into a large central vein. Nurses access the port with a needle instead of starting a new IV each visit. Patients often keep these devices for months or years.

The catheter tubing is made from polyurethane blended with barium sulfate. Barium sulfate makes the catheter visible on X-ray imaging. Plaintiffs allege those particles were distributed unevenly during manufacturing. Over time, they say, the particles separate from the surrounding material. That process leaves microscopic pits, cracks, and roughened surfaces on the catheter. Bacteria attach to rough surfaces far more easily than smooth ones. As a result, plaintiffs argue, the device becomes a platform for biofilm.

Biofilm is the core injury theory in a Bard PowerPort infection lawsuit. Once bacteria form biofilm on a catheter, antibiotics frequently cannot clear it. The infection can seed the bloodstream repeatedly. The CDC classifies this pattern of injury as a central line-associated bloodstream infection. Reported outcomes include sepsis, septic shock, endocarditis, bone infection, emergency explant surgery, and interrupted cancer treatment. Some families have filed wrongful death claims. Notably, the FDA has not recalled the PowerPort over barium sulfate degradation, and Bard denies any defect.

Case Timeline

Last checked: July 23, 2026

  • July 01, 2026 (Case Status): More than 3,300 cases remain pending in MDL 3081, with the next bellwether trial, the first involving a catheter fracture claim, set for August 18, 2026, and no global settlement reached. (Court Record)
  • May 08, 2026 (Ruling): The jury in the first bellwether returned a defense verdict for Bard and Becton Dickinson on failure to warn, failure to instruct, and consumer fraud, but deadlocked on the design defect claim. (Court Record)
  • April 21, 2026 (Bellwether Date): The first bellwether trial, Cook v. C.R. Bard/Becton Dickinson, an infection case, began before Judge Campbell in Phoenix. (Court Record)
  • August 08, 2023 (Other): The JPML centralized federal Bard implanted port catheter lawsuits as MDL No. 3081 in the U.S. District Court for the District of Arizona before Judge David G. Campbell. (Court Record)

MDL Case Status and Key Facts

MDL Number MDL No. 3081
Official Case Name In re: Bard Implanted Port Catheter Products Liability Litigation
Presiding Judge Senior U.S. District Judge David G. Campbell
Federal District U.S. District Court, District of Arizona (Phoenix)
Centralized August 8, 2023, by the JPML
Approximate Pending Cases Roughly 3,500 as of mid-2026
First Bellwether Result Split verdict, May 2026 (Cook v. Becton Dickinson)
Next Bellwether Trial August 18, 2026
Additional Trial Settings October 13, 2026; December 1, 2026; February 2, 2027
Global Settlement None reached as of July 2026

The Judicial Panel on Multidistrict Litigation centralized these cases in Arizona in August 2023. The docket has grown steadily since then. Every Bard PowerPort infection lawsuit filed in federal court is now coordinated before Judge Campbell for pretrial purposes. Consolidation lets the parties share discovery and expert work. Cases can later return to their home districts for trial.

The first bellwether trial began April 21, 2026, and ended in May. The jury rejected the failure-to-warn, failure-to-instruct, and consumer fraud claims. However, jurors deadlocked on design defect and unlawful trade practices. That was a partial defense win rather than a clean one. Both sides took away useful information. The second bellwether, set for August 18, 2026, will be the first catheter fracture case tried.

Who Qualifies for the Bard PowerPort Infection Lawsuit?

Eligibility for a Bard PowerPort infection lawsuit generally starts with device identification. You must show you received a Bard-manufactured port. Common model families include the PowerPort isp, SlimPort, ClearVUE, Titanium, and M.R.I. Implantable Port. Most claims involve devices implanted from roughly 2010 forward. Typically, the port was placed for chemotherapy, long-term antibiotics, dialysis access, or IV nutrition.

Next comes the injury requirement. Qualifying injuries usually include a documented bloodstream infection, sepsis, septic shock, bacterial endocarditis, or osteomyelitis. Many qualifying cases also involved emergency removal of the port. Hospitalization strengthens a claim considerably. For example, a positive blood culture paired with an explant operative report is strong support. Minor site redness that resolved on its own generally will not qualify.

Evidence matters more than memory in these cases. Attorneys typically request implant records, the device lot or sticker, blood culture results, imaging, hospital discharge summaries, and explant records. If the removed catheter was preserved, that is valuable. In most cases, your law firm can request records on your behalf. Statutes of limitation vary widely by state, and some are short. Consult a licensed attorney promptly rather than waiting for more information.

How to File a Bard PowerPort Infection Lawsuit Claim

Filing a Bard PowerPort infection lawsuit follows a fairly standard MDL path. Start by collecting your medical records and any device documentation you already have. Then consult a licensed product liability attorney with MDL experience. Most work on contingency, so there is typically no upfront fee. Ask directly how many port catheter cases the firm handles and who will manage yours.

Your attorney will then evaluate whether your case fits the MDL criteria. Cases may be filed directly into MDL 3081 under the court’s direct filing procedures. Alternatively, a case filed in your home federal district gets transferred to Arizona. Some claims belong in state court instead, depending on the parties involved. Your lawyer makes that venue decision.

After filing, you must complete a Plaintiff Fact Sheet. This is a detailed questionnaire about your medical history, device, and injuries. Deadlines are firm. Incomplete or late fact sheets have led to dismissals in many MDLs. As a result, prompt cooperation with your legal team is essential. Statutes of limitation are unforgiving, so do not delay a consultation.

Settlement Updates and What to Expect

No global settlement exists in the Bard PowerPort infection lawsuit as of July 2026. Anyone promising a set payout is not describing reality. The split verdict in the first bellwether left the central design defect question unresolved. That outcome gave neither side a decisive advantage. Court-supervised settlement discussions are expected as more trials conclude.

📨 Get Free Mass Tort Guides Alerts

Free · No spam · Unsubscribe anytime

Bellwether trials exist to generate settlement information. Defendants watch which claims resonate with juries. Plaintiffs watch which injuries draw the strongest response. Typically, meaningful settlement talks begin only after several trials produce a pattern. The trial settings running through February 2027 should sharpen that picture considerably.

Individual recoveries vary a great deal. Amounts depend on infection severity, length of hospitalization, permanent organ damage, treatment delays, lost income, and whether a death occurred. Applicable state law also affects value. No one can guarantee compensation, and no honest lawyer will quote you a figure early. However, you may qualify for a claim if your records support the injury. A licensed attorney can assess your specific situation.

State-by-State Considerations

State law travels with your case even inside a federal MDL. The court applies the substantive law of the state where your claim arose. That means deadlines, damage caps, and comparative fault rules differ from plaintiff to plaintiff. Some states impose statutes of repose that bar older device claims entirely. Others follow a discovery rule that starts the clock when the injury was reasonably discoverable.

Arizona hosts the MDL, but plaintiffs come from every state. California, Texas, Florida, New York, and Pennsylvania contribute large numbers of claims. Texas applies a products statute of repose and innocent-seller protections. Florida shortened its general negligence deadline in 2023. Review our tort reform by state comparison and the individual guides for California, Texas, Florida, and Pennsylvania. Then confirm the details with a licensed attorney in your state.

Frequently Asked Questions

Has the Bard PowerPort been recalled because of infections?

No. The FDA has not issued a recall tied to barium sulfate degradation or infection risk. Earlier Class II recalls in 2019 and 2020 involved a tunneler component and a ClearVUE Slim catheter lock, not the infection theory in this litigation. You can search device actions through the FDA medical device database.

Can I still join if my port was removed years ago?

Possibly. A Bard PowerPort infection lawsuit depends on your state’s statute of limitations and any discovery rule that applies. Some states start the clock when you learned the device may have caused the harm. Have a licensed attorney review your dates immediately, because these deadlines are strict.

How long will the Bard PowerPort infection lawsuit take to resolve?

There is no fixed timeline, and large device MDLs commonly run several years. The trials scheduled through February 2027 should clarify the litigation’s direction. Your own case may resolve sooner or later depending on settlement developments and your individual facts.

Check If You May Qualify

Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.

Official Sources & Resources

For verified mass tort and MDL information:

  • JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
  • DOJ: justice.gov — settlement announcements and press releases
  • FDA: fda.gov — drug recalls, warning letters, and safety alerts
  • CDC: cdc.gov — health condition data and exposure guidelines
  • EPA: epa.gov — environmental contamination data
  • Cornell LII: law.cornell.edu — plain-English legal definitions

Content last reviewed July 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.

Related Guides

Complete a short case review to see whether your diagnosis, Bard PowerPort implant history, and records may fit current attorney screening criteria. Submitting information does not guarantee representation, compensation, or participation in any lawsuit or settlement.

Free Case Review

Important: Legal deadlines can be time sensitive and vary by state, diagnosis date, exposure history, and other facts. Submitting information through this website does not file a lawsuit, preserve your rights, create an attorney-client relationship, or guarantee that any attorney will contact or represent you. If you do not receive a response, or if you are unsure about a filing deadline, you should promptly contact a qualified attorney of your choice to discuss your specific situation.

About this page: MassTortInfo.com is an informational publishing platform and a marketing / referral platform. We are not a law firm, settlement administrator, claims administrator, or government agency, and we do not provide legal advice. No attorney-client relationship is created by using this site or submitting any form. Submitting a form does not guarantee representation, compensation, eligibility, or participation in any lawsuit or settlement. This page contains paid advertising, and we may be compensated if you submit a case review. See our Terms of Service, Privacy Policy, and Disclaimer & Advertising Disclosure.

Going through divorce too? Compare state laws at Divorce Help Guide. Affected by a recalled drug as a Medicare patient? See Medicare Cover Guide. Just diagnosed with a serious illness? Compare life insurance at Life Insure Guide. PFAS in your water? Check homeowners coverage at Home Insure Guide.